20160128 EGA Regulatory and Scientific Affairs Conferenc

Inflation’s Impact on Medicine Supply: Challenges for the Off-Patent Industry

19 October 2022

Victor Mendonça, chair of the Generic Market Access Committee at […]

Read more

EU supply chain regulation: what will it mean for companies attending CPHI?

17 October 2022

Ahead of her session on “Manufacturing Excellence” at CPHI Frankfurt […]

Read more

Inflation drives pharma manufacturing to focus on sustainability

11 October 2022

Inflation is at an all-time high, opening an opportunity for […]

Read more

Europe’s generic drugmakers say they may cut output due to energy bills

28 September 2022

The generic drug industry lobby group Medicines for Europe on […]

Read more

Correo Farmaceutico – Elisabeth Stampa Stampa, Presidenta de Medicines for Europe y Consejera Delegata de Medichem

31 March 2022


New reports address generics pricing, innovation in the EU

2 December 2021


Read more

Open letter: Urgent call to amend the Temporary State Aid Framework to achieve the Recovery and Resiliency Facility objectives

17 November 2021


Margaritis Schinas and Adrian Van Den Hoven visited ELPEN

15 November 2021


Digitalisation the key to efficient EU pharmaceutical regulation and easing of localised drug shortages

27 October 2021

“Digitalisation the key to efficient EU pharmaceutical regulation and easing […]

Read more

“Central Role For Industry Beckons As Europe Rebuilds After COVID” – Interview to Rebecca Guntern

25 October 2021

Generics And Biosimilars Must Become A Central Policy Pillar, Says […]

Read more

Subscribe to our newsletter